W
WuXi Diagnostics
Health Tech & Medtech · Pudong, China · Founded 2018
Integrated diagnostics platform for multidisciplinary clinical data analysis MoreLess
WuXi Diagnostics is a diagnostics company that focuses on integrating multi-omics clinical data from various technologies to provide comprehensive diagnostic solutions. Established in 2018 as a joint venture between WuXi AppTec and the Mayo Clinic, the company aims to bridge diagnostic research with clinical practice. The company is led by CEO Jason Liu.
The firm operates an open-access innovation platform that utilizes clinical big data and algorithms to create diagnostic services and products. This model supports healthcare providers with solutions for the entire disease management process, including screening, early diagnosis, risk assessment, precision diagnosis, clinical decision support, and prognosis management. WuXi Diagnostics serves clients such as hospitals, doctors, pharmaceutical companies, and health insurance groups. Its business model is centered on developing and commercializing a pipeline of diagnostic products and services, often through strategic collaborations. A key product is the Enabling Solution Package (ESP), which uses algorithms for early disease diagnosis and management.
Headquartered in Shanghai, China, WuXi Diagnostics also has a CAP-accredited Independent Clinical Laboratory in Shanghai, an ISO13485-certified production facility in Suzhou, and a research and development center in Rochester, Minnesota, at the Mayo Clinic's headquarters. The company has achieved significant milestones, including a $150 million Series B funding round in February 2021, with investors like Thermo Fisher Scientific, Shiyu Capital, and YF Capital. This funding is intended to enhance its R&D pipeline and expand its global market presence. During the COVID-19 pandemic, WuXi Diagnostics collaborated with Thermo Fisher and the Mayo Clinic to develop antibody tests.
Keywords: integrated diagnostics, clinical diagnostic services, multi-omics data, diagnostic platform, precision medicine, disease management, clinical decision support, diagnostic R&D, early diagnosis, esoteric testing, molecular diagnosis, next-generation sequencing, clinical big data, diagnostic algorithms, healthcare innovation, in-vitro diagnostics, biopharmaceutical services, laboratory services
Company overview
WuXi Diagnostics company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2018
- Headquarters
- Pudong, China
- Employees
- 39
- Open positions
- 1
- Dealroom signal
- 33.1
Valuation & funding
WuXi Diagnostics funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Feb 2021 | $150M | $600M | Thermo Fisher Scientific · Sunland Capital · ABC International Holdings · CCBI Tech Venture | — |
| SERIES AOther financing | Oct 2019 | $0 | — | Undisclosed | — |
| SERIES AOther financing | Jan 2019 | $0 | — | YunFeng Capital | — |
| SEEDOther financing | Jan 2018 | $0 | — | Undisclosed | — |
Growth signals
WuXi Diagnostics website traffic
Latest recorded traffic for WuXi Diagnostics is 680 monthly website visits, up 353.3% over the last three months. WuXi Diagnostics's team declined 2.5% over the past year.
Hiring
Open positions at WuXi Diagnostics
Current openings linked to this company in Dealroom.
Comparisons
WuXi Diagnostics compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
WuXi Diagnostics's talent
Source: Dealroom Talent Intelligence.
Investors
6 investors on WuXi Diagnostics's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where WuXi Diagnostics has talent and traffic
team presence
In the news
Latest news about WuXi Diagnostics
Recent press, funding announcements, and product moves mentioning WuXi Diagnostics — open to read from the original sources.
Market sentiment
What the market is saying about WuXi Diagnostics
An AI-synthesized read of the highest-engagement posts about WuXi Diagnostics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See WuXi Diagnostics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.